Abstract
The Aryl Hydrocarbon Receptor Defines a Unique Genomic and Immune Signature in AML Characterized By Monocytic Differentiation, Venetoclax Resistance and Is Targetable By Ahr Antagonist
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have